Viewing Study NCT04240106


Ignite Creation Date: 2025-12-26 @ 2:41 PM
Ignite Modification Date: 2025-12-26 @ 2:41 PM
Study NCT ID: NCT04240106
Status: COMPLETED
Last Update Posted: 2024-02-16
First Post: 2020-01-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
Sponsor: MedSIR
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module